Suanfarma Suanfarma

X

Find Iguratimod manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Iguratimod
Also known as: 123663-49-0, N-(7-(methylsulfonamido)-4-oxo-6-phenoxy-4h-chromen-3-yl)formamide, Careram, Kolbet, T-614, Iguratimod [inn]
Molecular Formula
C17H14N2O6S
Molecular Weight
374.4  g/mol
InChI Key
ANMATWQYLIFGOK-UHFFFAOYSA-N
FDA UNII
4IHY34Y2NV

Iguratimod is under investigation in Rheumatoid Arthritis.
1 2D Structure

Iguratimod

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide
2.1.2 InChI
InChI=1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20)
2.1.3 InChI Key
ANMATWQYLIFGOK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3
2.2 Other Identifiers
2.2.1 UNII
4IHY34Y2NV
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-formylamino-7-methylsulfonylamino-6-phenoxy-4h-1-benzopyran-4-one

2. T 614

3. T-614

2.3.2 Depositor-Supplied Synonyms

1. 123663-49-0

2. N-(7-(methylsulfonamido)-4-oxo-6-phenoxy-4h-chromen-3-yl)formamide

3. Careram

4. Kolbet

5. T-614

6. Iguratimod [inn]

7. Iremod

8. 4ihy34y2nv

9. 3-formylamino-7-methylsulfonylamino-6-phenoxy-4h-1-benzopyran-4-one

10. Ncgc00181783-02

11. T614

12. N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide

13. N-[7-methanesulfonamido-4-oxo-6-(phenoxy)chromen-3-yl]formamide

14. N-(7-((methylsulfonyl)amino)-4-oxo-6-phenoxy-4h-1-benzopyran-3-yl)formamide

15. Unii-4ihy34y2nv

16. Colvet

17. T 614

18. Iguratimod- Bio-x

19. Iguratimod [mi]

20. Iguratimod (jan/inn)

21. Iguratimod [jan]

22. Dsstox_cid_28897

23. Dsstox_rid_83165

24. Iguratimod [who-dd]

25. Dsstox_gsid_48971

26. Schembl26326

27. Gtpl9736

28. Chembl2107455

29. Dtxsid0048971

30. Iguratimod, >=98% (hplc)

31. Chebi:31689

32. Bcp04206

33. Tox21_113422

34. Bdbm50458537

35. Mfcd00882374

36. S5648

37. Akos015888743

38. Zinc100018451

39. Ccg-268349

40. Cs-0617

41. Db12233

42. Sb16814

43. Ncgc00181783-01

44. Ncgc00181783-03

45. As-12959

46. Bi164569

47. Hy-17009

48. A3484

49. Cas-123663-49-0

50. Ft-0654508

51. I0945

52. C71931

53. D01146

54. 663i490

55. A805134

56. Sr-01000945251

57. J-521483

58. Sr-01000945251-1

59. Q13575264

60. N-(3-formamido-4-oxo-6-phenoxy-4h-chromen-7-yl)methanesulfonamide

61. N-[7-(methanesulfonamido)-4-oxo-6-phenoxy-4h-chromen-3-yl]formamide

62. N-[7-(methanesulfonamido)-4-oxo-6-phenoxy-chromen-3-yl]formamide;iguratimod

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 374.4 g/mol
Molecular Formula C17H14N2O6S
XLogP31.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass374.05725734 g/mol
Monoisotopic Mass374.05725734 g/mol
Topological Polar Surface Area119 Ų
Heavy Atom Count26
Formal Charge0
Complexity665
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY